PD

Pritesh Dashmukhbhai Shah

Active Director Director DIN 08763131
DIN 08763131 First appointment Jun 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2020
Shareholding value •••• Premium profile

About Pritesh Dashmukhbhai Shah

Data last updated:

Pritesh Dashmukhbhai Shah is a Director at Jemon Pharmaceuticals Private Limited (since 2020). The company operates in Pharma. Jemon Pharmaceuticals Private Limited reported revenue of ₹2.86 Cr (FY 2025).

DIN 08763131
Primary Designation Director
Industry Pharma
First Appointment 15 Jun 2020
Oldest Company Age 6 yrs
Largest company Jemon Pharmaceuticals Private Limited · ₹2.86 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Jun 20202020₹2.86 Cr (FY 2025)Active

Board colleagues of Pritesh Dashmukhbhai Shah

Directorship timeline

Open interactive timeline →
Jemon Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Pritesh Dashmukhbhai Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pritesh Dashmukhbhai Shah

Pritesh Dashmukhbhai Shah currently holds 1 directorship: Jemon Pharmaceuticals Private Limited (Director, since 15 Jun 2020, revenue ₹2.86 Cr (FY 2025)).

Pritesh Dashmukhbhai Shah was first appointed on 15 Jun 2020 as Director at Jemon Pharmaceuticals Private Limited.

The current boards of Pritesh Dashmukhbhai Shah's companies include Bhaveshkumar Patel (Jemon Pharmaceuticals Private Limited), Samirkumar Bhupendrabhai Patel (Jemon Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available